CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial

Michaud, Tzeyu L, Wilson, Kathryn E, Katula, Jeffrey A, You, Wen, Estabrooks, Paul A · 2023 · Translational Behavioral Medicine

Abstract

Although technology-assisted diabetes prevention programs (DPPs) have been shown to improve glycemic control and weight loss, information are limited regarding relevant costs and their cost-effectiveness. To describe a retrospective within-trial cost and cost-effectiveness analysis (CEA) to compare a digital-based DPP (d-DPP) with small group education (SGE), over a 1-year study period. The costs were summarized into direct medical costs, direct nonmedical costs (i.e., times that participants spent engaging with the interventions), and indirect costs (i.e., lost work productivity costs). The CEA was measured by the incremental cost-effectiveness ratio (ICER). Sensitivity analysis was performed using nonparametric bootstrap analysis. Over 1 year, the direct medical costs, direct nonmedical costs, and indirect costs per participant were $4,556, $1,595, and $6,942 in the d-DPP group versus $4,177, $1,350, and $9,204 in the SGE group. The CEA results showed cost savings from d-DPP relative to SGE based on a societal perspective. Using a private payer perspective for d-DPP, ICERs were $4,739 and $114 to obtain an additional unit reduction in HbA1c (%) and weight (kg), and were $19,955 for an additional unit gain of quality-adjusted life years (QALYs) compared to SGE, respectively. From a societal perspective, bootstrapping results indicated that d-DPP has a 39% and a 69% probability, at a willingness-to-pay of $50,000/QALY and $100,000/QALY, respectively, of being cost-effective. The d-DPP was cost-effective and offers the prospect of high scalability and sustainability due to its program features and delivery modes, which can be easily translated to other settings.

Overview

Integrity signals

Registry

Crossref · 10.1093/tbm/ibad008

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 52 references

Research works printed but not linked: 2

  1. International Diabetes Federation, 2021
  2. Centers for Disease Control and Prevention, 2020, National diabetes statistics report, 2020, 12

Cited by

See all 12

Metadata

Authors
Michaud, T. L., Wilson, K. E., Katula, J. A., You, W., & Estabrooks, P. A.
Affiliations
  • University of Nebraska Medical Center (US)
  • Georgia State University (US)
  • Wake Forest University (US)
  • University of Virginia (US)
  • University of Utah (US)
Corresponding author
Michaud, Tzeyu L
Venue
Translational Behavioral Medicine
Published
2023-02-21
Volume
13
Issue
7
Pages
501-510
ISSN
  • 1613-9860 (ISSN-L)
  • 1869-6716
OpenAlex
W4321437515
Cited by
12
References
52
Citations by year
2026: 1 · 2025: 4 · 2024: 7
FWCI
2.44
Type
journal article
Language
en
Open access
closed
Locations
  • Translational Behavioral Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Omada Health
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
Diabetes Prevention Program, digital health interventions, cost-effectiveness, small group instruction, HbA1c reduction, weight loss, quality-adjusted life years, incremental cost-effectiveness ratio, type 2 diabetes prevention
MeSH terms
Cost-Effectiveness Analysis, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Humans, Retrospective Studies, Weight Loss

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial. https://app.cochat.ai/papers/10.1093/tbm/ibad008
The paper
Michaud, T. L., Wilson, K. E., Katula, J. A., You, W., & Estabrooks, P. A. (2023). Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial. Translational Behavioral Medicine. https://doi.org/10.1093/tbm/ibad008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.